189 related articles for article (PubMed ID: 28287608)
1. Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development.
Shi ZD; Soh CL; Zhu Z; Huangfu D
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28287608
[TBL] [Abstract][Full Text] [Related]
2. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
Zhu Z; González F; Huangfu D
Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
[TBL] [Abstract][Full Text] [Related]
3. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.
González F; Zhu Z; Shi ZD; Lelli K; Verma N; Li QV; Huangfu D
Cell Stem Cell; 2014 Aug; 15(2):215-226. PubMed ID: 24931489
[TBL] [Abstract][Full Text] [Related]
4. Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.
Zhu Z; Li QV; Lee K; Rosen BP; González F; Soh CL; Huangfu D
Cell Stem Cell; 2016 Jun; 18(6):755-768. PubMed ID: 27133796
[TBL] [Abstract][Full Text] [Related]
5. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
6. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.
Soh CL; Huangfu D
Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
9. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
[TBL] [Abstract][Full Text] [Related]
10. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.
Blair JD; Bateup HS; Hockemeyer DF
J Vis Exp; 2016 Feb; (108):e53583. PubMed ID: 26863600
[TBL] [Abstract][Full Text] [Related]
12. Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells.
Shahryari A; Moya N; Siehler J; Wang X; Burtscher I; Lickert H
CRISPR J; 2021 Aug; 4(4):491-501. PubMed ID: 34406042
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.
Yang D; Scavuzzo MA; Chmielowiec J; Sharp R; Bajic A; Borowiak M
Sci Rep; 2016 Feb; 6():21264. PubMed ID: 26887909
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
15. Rates of homology directed repair of CRISPR-Cas9 induced double strand breaks are lower in naïve compared to primed human pluripotent stem cells.
Dodsworth BT; Hatje K; Meyer CA; Flynn R; Cowley SA
Stem Cell Res; 2020 Jul; 46():101852. PubMed ID: 32521498
[TBL] [Abstract][Full Text] [Related]
16. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
Hendriks WT; Jiang X; Daheron L; Cowan CA
Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
[TBL] [Abstract][Full Text] [Related]
18. BIG-TREE: Base-Edited Isogenic hPSC Line Generation Using a Transient Reporter for Editing Enrichment.
Brookhouser N; Tekel SJ; Standage-Beier K; Nguyen T; Schwarz G; Wang X; Brafman DA
Stem Cell Reports; 2020 Feb; 14(2):184-191. PubMed ID: 32004495
[TBL] [Abstract][Full Text] [Related]
19. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development.
Shi ZD; Lee K; Yang D; Amin S; Verma N; Li QV; Zhu Z; Soh CL; Kumar R; Evans T; Chen S; Huangfu D
Cell Stem Cell; 2017 May; 20(5):675-688.e6. PubMed ID: 28196600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
